Ulrik Charlotte Suppli, Søes-Petersen Ulrik, Backer Vibeke, Lange Peter, Harving Henrik, Plaschke Peter
Department of Heart and Lung Diseases, Hvidovre Hospital, Copenhagen.
J Asthma. 2008 Aug;45(6):507-11. doi: 10.1080/02770900802017736.
Asthma is a variable disease, and therapy should be tailored accordingly. The aim of this study was to explore patterns of self-management in response to disease variability in adult asthmatics.
Adult asthmatics (n = 509), recruited through a web-based panel, answered a questionnaire concerning asthma knowledge, compliance, and treatment, including specified treatment options, through the Internet.
Two-thirds of the patients on inhaled corticosteroids (ICS) stepped-up and down their daily dose without prior contact to their doctor, and more than 50% took less ICS than prescribed during periods with fewer symptoms. In case of deterioration, 57% of the patients would only increase their reliever medication, whereas 23% would also increase their controller medication, although 59% were instructed by their doctor to do so. The self-perceived severity of asthma (graded as mild, moderate or severe) was not associated with the patients' response pattern. The preferred treatment strategy, differing primarily with regard to dosing and timing of controller medication, was associated with feeling safe about self-adjustment of controller medication (p < 0.001), but not with self-reported knowledge of asthma (p > 0.5).
In case of deterioration, the majority of adult asthmatics only increase their reliever medication, although instructed by their doctors also to increase their controller medication. Furthermore, the patients' preferred strategy for management of disease variability seems not to be driven by their knowledge of the disease.
哮喘是一种多变的疾病,治疗应相应地进行调整。本研究的目的是探讨成年哮喘患者针对疾病变异性的自我管理模式。
通过网络小组招募了509名成年哮喘患者,他们通过互联网回答了一份关于哮喘知识、依从性和治疗的问卷,包括特定的治疗选择。
三分之二使用吸入性糖皮质激素(ICS)的患者在未事先联系医生的情况下自行增减每日剂量,超过50%的患者在症状较少的时期使用的ICS低于规定剂量。在病情恶化时,57%的患者只会增加缓解药物,而23%的患者也会增加控制药物,尽管59%的患者得到医生的指示要这样做。患者自我感知的哮喘严重程度(分为轻度、中度或重度)与患者的应对模式无关。首选的治疗策略主要在控制药物的剂量和使用时间方面有所不同,与对控制药物自我调整的安全感相关(p<0.001),但与自我报告的哮喘知识无关(p>0.5)。
在病情恶化时,大多数成年哮喘患者仅增加缓解药物,尽管医生指示他们也增加控制药物。此外,患者针对疾病变异性的首选管理策略似乎并非由其疾病知识驱动。